The placenta is the extraembryonic organ that supports the fetus during intrauterine life. Although placental dysfunction results in major disorders of pregnancy with immediate and lifelong consequences for the mother and child, our knowledge of the human placenta is limited owing to a lack of functional experimental models 1 . After implantation, the trophectoderm of the blastocyst rapidly proliferates and generates the trophoblast, the unique cell type of the placenta. In vivo, proliferative villous cytotrophoblast cells differentiate into two main sub-populations: syncytiotrophoblast, the multinucleated epithelium of the villi responsible for nutrient exchange and hormone production, and extravillous trophoblast cells, which anchor the placenta to the maternal decidua and transform the maternal spiral arteries 2 . Here we describe the generation of long-term, genetically stable organoid cultures of trophoblast that can differentiate into both syncytiotrophoblast and extravillous trophoblast. We used human leukocyte antigen (HLA) typing to confirm that the organoids were derived from the fetus, and verified their identities against four trophoblast-specific criteria 3 . The cultures organize into villouslike structures, and we detected the secretion of placental-specific peptides and hormones, including human chorionic gonadotropin (hCG), growth differentiation factor 15 (GDF15) and pregnancyspecific glycoprotein (PSG) by mass spectrometry. The organoids also differentiate into HLA-G + extravillous trophoblast cells, which vigorously invade in three-dimensional cultures. Analysis of the methylome reveals that the organoids closely resemble normal first trimester placentas. This organoid model will be transformative for studying human placental development and for investigating trophoblast interactions with the local and systemic maternal environment.
+ trophoblast cells (dark blue) are shown. dec, decidual; DG, decidual gland; SA, spiral artery; Pl, placental. b, Immunohistochemical staining for Ki67 in early first trimester placenta (6-8 weeks gestation) compared to late first trimester placenta (10-12 weeks gestation). The proportion of proliferative cells is greatly reduced towards the end of the first trimester, and the cells are localized mostly in the CCCs. Representative images from n = 6 for each tissue type. Scale bars, 100 μm. c, Immunohistochemical staining for EPCAM in first trimester placenta (6-8 weeks gestation) and cell clusters from first trimester placental digests. The experiment was independently repeated twice with similar results. Arrowheads show that the VCT and CCCs are EPCAM + , and these cells are present in the cell clumps from the placental digests. Scale bars, 50 μm (placenta) and 200 μm (placental digest). d, Time course for derivation of trophoblast organoids from one placental isolate. Bright-field images of Matrigel drops after seeding placental digests starting from passage 0 (day 0), until the generation of homogenous trophoblast organoids (passage 2, day 7). For passages 0 and 1, time points at days 0 and 7 are shown. Passage 2 (day 7) is shown together with a magnified view of trophoblast organoids (boxed area). The experiment was independently repeated for all organoid cultures with similar results. Scale bars, 500 μm and 200 μm (magnified view). Table 1a ). The growth factors HGF, PGE2 and Y-27632 (a ROCK inhibitor) increase cell viability and growth and, when they are combined with TOM, there is rapid expansion of cells within a week (Fig. 1d, Supplementary Table 1b) . After the first passage, organoid structures appear and homogeneous trophoblast organoids are established within two passages (10-14 days) , with an efficiency of 91% (20 out of 22 patient samples). To confirm their fetal origin, we used microsatellite analysis and HLA typing (Extended Data Table 1 ). Derivation of the organoids in TOM in the absence of individual media components reveals that EGF is the most important, with effects also seen with Y-27632, A83-01 and CHIR99021. We have now derived trophoblast organoids that are genetically stable after many passages (Extended Data Fig. 2b, c) ; three randomly selected cultures are still growing after a year (Supplementary Table 1c) , are healthy and show active mitochondrial function (Extended Data Fig. 2d ). Maternal epithelial cells are always detectable by flow cytometry in placental cell isolates. Nicotinamide enriches for cystic structures that resemble decidual glandular organoids at early stages of derivation (Extended Data Fig. 2a) , and microsatellite analysis and HLA typing confirmed their maternal origin (Extended Data Table 2 ). By selecting the appropriate media, we can derive both decidual glandular and trophoblast organoid cultures from the same pregnancy 11 (Extended Data Fig. 2e ). This highlights the importance of verifying the maternal or fetal origin of any cultures derived from decidual or placental cell isolates.
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The trophoblast identity of the organoids was verified on the basis of our previously defined criteria: they express the markers GATA3, KRT7, EGFR, TFAP2A and TFAP2C; they lack expression of HLA class I molecules; they express ELF5 and its promoter is hypomethylated; and they express microRNAs (miRNAs) from the chromosome 19 miRNA cluster (C19MC) at similar or higher levels than the choriocarcinoma lines JEG-3 and JAR 3 ( Fig. 2a-d , Extended Data Fig. 3a-f ). To assess how well the trophoblast organoids recapitulate their tissue of origin in an unbiased approach, we performed a microarray analysis of established organoids and compared them to first trimester placental villi (also containing stromal, Hofbauer and endothelial cells) and cultured villous stromal cells. To check for maternal cell contamination, decidual glandular organoids were included. The results were analysed by principal component analysis and hierarchical clustering (Fig. 2e , f, Extended Data Fig. 4a ). PC1 shows trophoblast organoids cluster closely to the placenta with enrichment for trophoblast-specific genes such as CGB3, GATA3 and PSG6 compared to the stromal cells and glandular organoids. PC2 highlights epithelial genes (for example CLDN3, TACSTD2 and KRT23) that are specific for trophoblast compared to other placental cells (Extended Data Fig. 4b ). Immunohistochemical analysis of placental villi and trophoblast organoids confirms that KRT23 is a trophoblast-specific keratin (Extended Data Fig. 4c ). Comparison of differentially expressed genes (fold change ≥ 2, adjusted P ≤ 0.05) between placental villi, trophoblast organoids and stromal cells highlights other genes of interest, such as PGF, CCNE1, ERBB3 and FOLR1; the translation of CCNE1 in trophoblast was validated by immunohistochemistry (Extended Data Fig. 4d, e) . The imprinted genes PEG3 and PEG10 are also highly expressed in the trophoblast organoids (Extended Data Fig. 4d ). Besides the known transcription factor genes GATA3 and TFAP2C, differentially expressed genes emerged such as ELF3 (Extended Data Fig. 5a, b) . Genome-wide methylation analysis revealed a high degree of correlation between trophoblast organoids and first trimester placental villi across different genomic elements compared to blood and brain (Fig. 2g) . The hypomethylation of the The experiment was independently repeated three times. c, Bisulfite sequencing of the ELF5 promoter region of trophoblast organoids (TOrg_7) and matched maternal leukocytes (positive control). The relative percentage of methylated cytosine residues (filled circles) is indicated. d, qPCR analysis for miR517-3p from the C19MC cluster on trophoblast organoids (n = 6), JEG-3 and JAR choriocarcinoma (ChC) cell lines (positive controls) and peripheral blood monocytes (PBMC) (low expression/negative control). The graph shows relative expression levels to the housekeeping gene RNU48. e, Principal component (PC) analysis of placental villi (n = 8); trophoblast organoids derived from different placentas, TOrg_1 (passage 4), TOrg_2 (passage 7), TOrg_3 (passage 6), TOrg_4 (passage 4) and TOrg_5 (passage 6) (n = 5); placental stromal cells (n = 5); and decidual organoids (n = 3). Analysis based on 12,673 probes. Organoids cluster more closely with placental villi on the PC1 axis. f, Clustered heat map of differentially expressed genes in first trimester placental villi (n = 8) (blue), trophoblast organoids (n = 5) (pink) and cultured placental villous stromal cells (n = 5) (green). g, Distribution of methylcytosine across genomic features is similar between trophoblast organoids (n = 4) and placental samples (n = 4). By contrast, the brain (n = 1) and maternal blood (n = 5) samples show distinct patterns, especially across CpG islands, gene bodies and LINE1 elements. Pearson's correlation coefficient (R) is indicated for each comparison compared to trophoblast organoid samples (all P < 2.2 × 10 −16 ). Density plots are scaled to area.
ELF5 promoter was also confirmed (Extended Data Fig. 5c, d) . Analysis of the promoter regions of genes with similar methylation patterns to Elf5 in mouse trophoblast stem cells shows that ELF5, EZR, TINAGL1 and LASP1 are similarly hypomethylated in human placental villi and trophoblast organoids 12 (Extended Data Fig. 5e, f) . Gene Ontology analysis of differentially expressed genes, represented by a chord diagram, shows terms that describe metabolic processes and cell-cell organization that converge on epithelial, developmental and hormonal pathways, and identified the genes FZD5 (WNT signalling), INSIG1 (insulin signalling), DHCR7 (cholesterol synthesis) and OCLN (polarity) (Extended Data Fig. 5g ).
Trophoblast organoids grow as complex structures that closely recapitulate the organisation of placental villi in vivo, where VCT stain for EPCAM and CDH1 (Fig. 3a, b) . The basement membrane is on the outside in contact with Matrigel, and syncytial masses line the central cavity (Extended Data Fig. 6a ). Similar to in vivo, VCT cells are Ki67 
and TP63
+ (Fig. 3b, Extended Data Fig. 6b , c). After incubation with EdU, approximately 30-40% of cells are proliferating when the organoids are small (100-200 μm diameter), with a notable decrease as they enlarge and differentiate (Extended Data Fig. 6d) . Expression of the syncytiotrophoblast (SCT) markers CD46 and CD71 is detected inside the organoids (Extended Data Fig. 6e ). The characteristic features of SCT were confirmed by electron microscopy, in which multinucleated areas with abundant secretory organelles and surface microvilli were detected (Fig. 3c ). Lacunae present within the syncytial areas resemble those found in vivo (Extended Data Fig. 6f, g ). GCM1 drives the fusion of VCT into SCT by upregulating ERVW-1 (also known as SYNCYTIN-1) 13, 14 . Using quantitative PCR (qPCR), we detected high expression levels of GCM1 and ERVW-1 in trophoblast organoids, comparable to those in the placental villi (Fig. 3d) . Thus, trophoblast organoids closely mimic the villous placenta both structurally and phenotypically. The SCT secretes proteins and hormones into the maternal systemic circulation that mediate maternal adaptations to pregnancy. We explored the secretory activity of trophoblast organoids using an unbiased proteomic analysis of the conditioned organoid medium by liquid chromatography-tandem mass spectrometry (LC-MS/MS) technology (Fig. 4a) . Among the most abundant peptides are placental-specific PSGs and INSL4, the functions of which , TOrg_5 (passage 6), TOrg_10 (passage 12), TOrg_12 (passage 4) and TOrg_14 (passage 5). b, ELISA for GDF15 secreted by trophoblast organoids (n = 6). The amount of GDF15 (ng ml −1 ) produced by trophoblast organoids (between days 7 and 10 after passaging) in 48 h is shown. c, ELISA for hCG-β secreted by trophoblast organoids (n = 5). The amount of hCG-β (ng ml −1 ) produced by trophoblast organoids (between days 7 and 10 after passaging) in 48 h is shown. d, Over-thecounter pregnancy test denoting 'pregnant' after being placed into a dish containing cultures of trophoblast organoids. Image reproduced with the permission of SPD Swiss Precision Diagnostics GmbH (SPD). Experiment was independently repeated twice.
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are unknown (Extended Data Table 3, Supplementary Table 2a-h) . Aldose reductase, which converts glucose to sorbitol, is also detected. High concentrations of sorbitol are present in first trimester placentas 15 . Hence, the organoids also mimic the villous placenta metabolically as well as endocrinologically. Peptides that induce physiological and metabolic adaptations during pregnancy, including hCG, KISS1 and CSH1, are all abundant, in addition to GDF15, which is implicated in hyperemesis gravidarum 16 . GDF15 and hCG are detected by ELISA, showing that full-length and appropriately folded hormones are secreted by trophoblast organoids (Fig. 4b, c) . Indeed, the 'pregnant' secretome of the organoids is evident using an over-the-counter pregnancy test kit (Fig. 4d) .
Human trophoblast also differentiates to EVT, a process that is crucial for proper placentation. EVT cells express HLA-G and invade decidual tissue to transform the spiral arteries 17 . In TOM, our trophoblast organoids show only sporadic HLA-G + cells (Extended Data Fig. 7a ). Long-term, two-dimensional monolayer cultures of human trophoblast cells derived from first trimester placentas that can differentiate into SCT and EVT were recently described 18 . By adapting this EVT differentiation protocol and culturing both our trophoblast organoids and primary villous explants in their EVT differentiation medium (EVTM) 18 , HLA-G + cells that migrate out of the organoids emerge, digest the Matrigel to form tracks, and eventually adhere to the plastic ( Fig. 5a -e, Extended Data Fig. 7b , Supplementary Videos 1-6). In vivo, EVT are generated at the base of the CCCs, where cells express ITGA2 10 . We used flow cytometry to confirm that, after exposure of organoids to EVTM, HLA-G + EVT appear and ITGA2 + cells disappear (Fig. 5e, f) .
In summary, we describe the generation of human trophoblast organoids that grow as complex three-dimensional structures with the fusion of VCT to hCG-secreting SCT, and anatomically and functionally closely resemble the villous placenta in vivo. In addition, we show differentiation to HLA-G + EVT cells that vigorously invade and digest Matrigel in 3D cultures. After the submission of our paper, a report was published that describes the generation of trophoblast organoids from pooled patient samples; however, to our knowledge, these cannot be cultured long-term and have not been fully characterized using the four trophoblast criteria 19 . Our results complement previous findings and mean that there are now two culture systems (2D and 3D) for human trophoblast 18 . Our 3D model has the advantage of organizing into villous structures that will allow analysis of morphogenetic events. We anticipate that these two different models will provide valuable tools across a range of disciplines. They can be used to study maternal-fetal transmission of xenobiotics, drugs and pathogens, and the proteins and hormones derived from the SCT 20 . Analysis of CCC formation and EVT differentiation in vitro will allow investigation of the decidual microenvironment on trophoblast function, such as the effect of glandular histotrophic nutrition and the influence of the distinctive uterine natural killer cells 21, 22 . Major unexplained disorders of pregnancy such as pre-eclampsia, still-birth and fetal growth restriction have their origins in aberrant placental development in the first trimester 23 . Trophoblast organoids can be used to study maternal-fetal interactions after implantation, and the maternal physiological, metabolic and hormonal changes that occur during pregnancy.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-018-0753-3. Table 1b) . Cultures were maintained in 5% CO 2 in a humidified incubator at 37 °C. Medium was replaced every 2-3 days. Small organoid clusters became visible by around day 7 and were passaged when at least 50% had reached a diameter of 200-300 μm (usually between days 7 and 10). Mechanical disruption was achieved with Eppendorf Explorer Plus automatic pipettes on a mix cycle of 99 rounds (4-5 times), maximum speed. Organoids from the same sample were initiated and maintained in the absence of each individual component to test its importance. Frozen stocks of organoids were made in 70% TOM, 20% FBS and 10% DMSO freezing medium and stored in liquid nitrogen. A step-by-step protocol of the derivation and maintenance of human trophoblast organoid cultures can be found at Nature Protocol Exchange 24 .
Generation of EVT cells from trophoblast organoids.
Trophoblast organoids were passaged and plated into 35-mm dishes or ibidi μ-dishes (Thistle Scientific 81156). Differentiation was achieved through the modification of a protocol described previously 18 . After passaging, organoids were maintained in TOM for 3-4 days and switched to EVT differentiation medium (EVTM: advanced DMEM/ F12, 0.1 mM 2-mercaptoethanol (Gibco 31350), 0.5% penicillin-streptomycin, 0.3% BSA (Sigma A8412), 1% ITS-X supplement (Gibco 51500-056), 100 ng ml −1 NRG1 (Cell Signaling 5218SC), 7.5 μM A83-01 (Tocris Biotechne 2939) and 4% knockout serum replacement (ThermoFisher 10828010)). When organoids showed outgrowth of cells (typically days 7-10), the medium was changed to EVTM without NRG1 for a further 7-10 days. For comparison, fresh placental villi were embedded in 300 μl Matrigel in ibidi μ-dishes and grown under the same conditions. Isolation of placental stromal cells. Placental villous stromal cells were isolated by digesting the tissue remaining after the initial trypsin and collagenase digests in 10-15 ml collagenase V in Ham's F12 containing 10% FBS, with gentle shaking at 37 °C for 5-10 min. The cell suspension was filtered through gauze, washed and pelleted. Cells were resuspended in Advanced DMEM/F12 with 10% FBS and additional l-glutamine, non-essential amino acids (Gibco 11140-035) and primocin (InvivoGen ant-pm-1) and seeded into tissue culture flasks. Cells were cultured to 80-90% confluency and passaged once before use. Isolation of PBMC. PBMC were isolated from blood by Pancoll-based (Pan-Biotech P04-60500) density gradient separation. PBMC viability was >95% by Trypan Blue exclusion. PBMC were resuspended in QIAzol lysis reagent (Qiagen 79306) for total RNA extraction following the supplier's protocol. Cell lines. Choriocarcinoma cell lines JEG-3 and JAR (used only as control cell lines for experiments in this study) were purchased from the American Type Culture Collection (ATCC) in 2015. Cells were expanded and frozen stocks were immediately made within a few passages of receipt of these cell lines. Early passage numbers were thawed for this study. They are routinely screened for their unique characteristics: HLA class I expression (JAR are negative) and HLA-G (JEG are positive) and have been tissue typed 3 . JEG-3 and JAR were not tested for mycoplasma upon receipt from the ATCC. Immunohistochemistry. Organoids were formalin-fixed and embedded as previously described 11 . Immunohistochemistry on sections of organoids and first trimester placentas was performed using heat-induced epitope retrieval buffers (A. Menarini) and Vectastain avidin-biotin-HRP reagents (Vector Lab PK-6100) as previously described 11 . Primary antibodies (Supplementary Table 3) were replaced with equivalent concentrations of isotype-matched mouse or rabbit IgG for controls. Images were captured with a Zeiss Axiovert Z1 microscope and Axiovision imaging software SE64 V4.8. Immunofluorescence and confocal microscopy. Trophoblast organoids were grown in 4-5 20-μl Matrigel drops in 35-mm ibidi μ-dishes and EdU and/or antibody labelling was performed as previously described 11 . EdU incubation was performed for 1 h at 37 °C in TOM containing 10 μM EdU. For primary and secondary antibodies used, see Supplementary Table 1d ). LIVE/DEAD Fixable Far Red Dead Cell Stain (Life Technologies L10119) was used for live/dead discrimination. Data were acquired using Cytek Development DxP8 (488/637/561). Data were analysed in FlowJo (Tree Star) and all compensation was applied digitally after acquisition. In situ hybridization assays. In situ hybridization for LGR5 was performed on 4-μm paraffin sections with the RNAscope 2.0 High definition assay (Advanced Cell Diagnostics) following the manufacturer's instructions. In brief, tissue sections were baked at 60 °C for 1 h, dewaxed with xylene, cleared in 100% ethanol and airdried before the standard protocol: 10 min in pre-treat buffer 1, 15 min in pre-treat buffer 2 and 30 min at 37 °C in pre-treat buffer 3 followed by incubation with the LGR5 probe (311021), positive-control probe UBC (310041) or negative-control probe dapB (310043) for 2 h at 40 °C. The signal was visualized with the amplification kit and DAB for 10 min. Sections were dehydrated, mounted in DPX (Sigma 44581) and imaged on a Zeiss Axiovert Z1 microscope with Axiovision imaging software SE64 V4.8. Electron microscopy. Trophoblast organoids were directly fixed in 35-mm dishes with 0.5% glutaraldehyde, 0.2 M sodium cacodylate buffer (pH 7.2) for 30 min and post-fixed and reduced with osmium tetroxide as previously described 11 . Ultrathin sections were examined in an FEI Tecnai G2 TEM at 80 kV. Images were acquired with MegaView III CCD and Soft Imaging Systems program. Samples from human placentas were fixed by immersion in 3% glutaraldehyde, 0.3% hydrogen peroxide in 0.1 mol l −1 1,4-piperazine diethane sulfonic acid (PIPES) buffer (pH 7). After 2 h at room temperature, tissue was washed for 30 min in 0.1 mol l −1 PIPES buffer. Secondary fixation was achieved by immersion in 1% osmium tetroxide in PIPES buffer for 1 h at room temperature. After washing, specimens were dehydrated in graded ethanol and embedded in Araldite epoxy resin. Ultrathin sections (50 nm) were cut on a Reichert-Jung Ultracut S (Reichert-Jung). Sections were counterstained with uranyl acetate, followed by lead citrate, before viewing in a Philips CM100 electron microscope (Philips Electronics). DNA extraction and quantification. The QIAamp DNA Blood Mini kit (Qiagen 51104) was used to extract genomic DNA from patients' blood for short tandem repeat analysis, HLA tissue typing and bisulfite sequencing. DNA was extracted from trophoblast organoids, decidual and placental tissues by digestion with ATL buffer (Qiagen 19076) and proteinase K (Sigma P4850), followed by purification steps with RNase A (Sigma R6513) and Protein Precipitation Solution (Qiagen 158910). DNA was precipitated with isopropanol and washed with 70% ethanol. DNA quality and concentration were determined in a Nanodrop ND-1000 Spectrophotometer.
Comparative genomic hybridization analysis. DNA from two independently derived trophoblast organoid samples at early and late passages was analysed with
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Agilent Sureprint G3 unrestricted CGH ISCA 8×60K array (Agilent G4450A). DNA samples from late passage organoids were compared to early passage organoids (hybridization control). DNA was diluted to 50 ng μl −1 and labelled using the Agilent kit following the manufacturer's instructions. Data analysis for segmentation and copy number calls was performed at a genome-wide resolution of 500 kb by the default analysis method, CGH v2 from the Agilent CytoGenomics software Edition 2.5.8.11 (Build 37). Short tandem repeat analysis and HLA typing. Microsatellite analysis was performed with the GenePrint PowerPlex16 System (Promega) involving fluorescent labelled multiplexed PCR amplification of 15 short tandem repeat (STR) loci and amelogenin sex-determining fragments. PCR fragment size resolution was achieved with capillary electrophoresis on a 3730XL DNA Analyzer (Applied Biosystems) before analysis of the raw data and STR allele calling with GeneMapper Versions 4 and 5 (Life Technologies) fragment analysis sizing and genotyping software. All typing was performed blinded. The Promega PowerPlex 16 kit was designed for forensic testing and has a sensitivity that can detect down to 5% contamination. It is used for monitoring of post-haematopoietic stem-cell transplant chimaerism 25, 26 . The DNA for HLA genotyping was processed via the workflows of the EFI accredited Clinical Histocompatibility Laboratory. Low resolution typing of the HLA-A, HLA-B and HLA-C genes was achieved with LABType kits (One Lambda), which rely on reaction patterns observed when sequence-specific DNA probes immobilized on fluorescent X-MAP polystyrene beads (Luminex) hybridize to biotin-labelled multiplexed gene-specific PCR amplicons. The hybrids were detected with a Liquichip 200 fluorimeter (QIAgen) and HLA allele assignment was from HLA Fusion software (One Lambda). Ultra-high resolution typing of HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1 and HLA-DPB1 was achieved with an 'in house' third generation sequencing pipeline using Pacific Biosciences' Single Molecule Real-Time DNA sequencing technology as previously described 27 . Bisulfite sequencing. Approximately 300 ng of DNA was used for bisulfite conversion performed with the EpiTect Bisulphite Kit (Qiagen 59110), according to the manufacturer's protocol. The ELF5 promoter region was amplified as described previously 28 . PCR products were cloned and sequenced, confirming representation of distinct alleles. Global DNA methylation analysis. Genomic DNA bisulfite was performed with the CEGX TrueMethyl kit (Cambridge Epigenetix /NuGEN) and used for microarray-based DNA methylation analysis, performed at GenomeScan (GenomeScan BV), on the HumanMethylation850 BeadChip (Illumina) and were scanned on the Illumina iScan system. The resulting iDAT files were imported and analysed by ChAMP (v2.9.10) 29, 30 . Samples were processed and filtered for a probe detection P-value of < 0.01, probes with a bead count of less than 3 in at least 5% of samples, no CpG and known single nucleotide polymorphisms at probe starts, probes aligning to several locations, and quality control using the on array control probes 31 . Of the total probes on the array, 755,577 passed the filtering and qualitycontrol steps. The BMIQ method was used to normalize the two probe types present on the array. Beta methylation values from the EPIC array range from 0 (unmethylated) to 1 (methylated) and are the equivalent of percentage methylation 32 . Genomic annotations were imported from FDb.InfiniumMethylation.hg19 and IlluminaHumanMethylationEPICmanifest
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. Genomic features in Fig. 2g comprise the following numbers of assayed CpGs (in organoids, placenta and maternal blood, respectively): CpG islands, 48,799, 48,799 and 13,576; promoters, 151,270, 151,270 and 88,621; gene bodies, 280,284, 280,284 and 117,138; LINE1, 48,799, 48,799 and 13,576. Density plots are scaled to area. LINE1 elements were downloaded as tables from the UCSC Genome browser for hg19 34 . Maternal blood samples (normal) are taken from ArrayExpress accession E-GEOD-66210. RNA extraction, quantification and quality control. Total RNA was isolated using the miRNeasy isolation kit (Qiagen 217004) with on-column DNase digestion (Qiagen 79254). Quantification of RNA was performed with the Quant-iT RiboGreen RNA Assay Kit (Thermo Fisher Scientific R11490) by measuring the intensity of fluorescence at 528 nm with a Synergy HT Multi-Mode Microplate Reader (BioTek Instruments) according to the manufacturer's instructions. RNA quality was assessed on the Agilent 2100 bioanalyzer (Thermo Fisher Scientific). RNA integrity number (RIN) of each tested sample was greater or equal to 8. Reverse transcription and qPCR. The expression of ELF5, ERVW-1 and GCM1 was analysed with Taqman Gene expression assays (Applied Biosystems). Total RNA (500 ng-1 μg) was reverse transcribed with Superscript VILO Reverse Transcriptase (Thermo Fisher Scientific 11754050) in the presence of random hexamers and RNase inhibitor following the supplier's instructions. qPCR was performed on 7900HT Fast Real-Time PCR system (Applied Biosystems) as previously described 11 . Relative expression levels were normalized to the geometric mean of the three housekeeping genes HPRT1, TOP1 and TBP using the 2 −∆Ct method. The expression of C19MC miRNAs hsa-miR-517-5p, hsa- miR-517(a, b)-3p, hsa-miR-526b-3p, hsa-miR-525-3p and reference gene RNU48 was analysed by TaqMan miRNA assays (Applied Biosystems). Total RNA (10 ng) was reverse transcribed using miRNA-specific stem-loop reverse transcription primers and TaqMan microRNA reverse transcription kit (Applied Biosystems 4366596) according to the supplier's instructions. qPCR assays were run with qPCRBIO Probe Mix Lo-ROX (PCR Biosystems) containing specific probes on an Eppendorf Mastercycler RealPlex 2 instrument. C t data were normalized to the RNU48 internal control by the 2 −∆Ct method. All qPCR reactions included no-template controls and minus reverse transcriptase controls (-RT). For further details and for Taqman Assay IDs for each gene, see Supplementary Methods. Microarray expression profiling and data analysis. The microarray experiment was performed at Cambridge Genomic Services at University of Cambridge with a species-specific Gene 2.1 ST Array Plate (Affymetrix) according to the manufacturer's instructions. In brief, 100 ng of total RNA was amplified for each sample with inline PolyA spike-in control and the WT PLUS amplification kit (Affymetrix). By using the in line hybridization controls, we successfully amplified samples with the GeneChip WT terminal labelling kit (Affymetrix). Plate arrays were processed on the GeneTitan instrument (Affymetrix) with the GeneTitan Hybridization, Wash and Stain kit (Affymetrix). Samples were hybridized to the array, washed, stained and scanned. CEL files generated were loaded in R using the oligo package from Bioconductor. The raw data were then processed after quality controls using the Robust Multichip Analysis method. The limma package (3.34.8) was used to make the comparisons, and results were corrected for multiple testing using the false discovery rate. Microarray probes without gene identifier (ensembl gene id) were filtered out. Initial quality control included principal component analysis and MDS plots. Finally, the quality of the data was assessed, and the correlation of the samples in the groups was compared. Heat maps were generated with the R package 'pheatmap' (1.0.8), which uses the Euclidean method. For the gene heat maps, the input is the normalized intensity matrix. GO terms enrichment was obtained with R package 'clusterProfiler' (3.6.0) with function 'enrichGO' , and chord plots were generated with the R package 'GOplot' (1.0.2). LC-MS/MS analysis of trophoblast organoid supernatants. Trophoblast organoids (day 10 after passaging) were grown in TOM and supernatants were collected after overnight incubation. The supernatants (500 μl) and an aliquot of growth media were acidified with 50 μl of 1% formic acid in water (v/v) and loaded directly onto an Oasis HLB Prime μ-elution 96 well SPE plate (Waters 186008052) and extracted as described previously 35 . The eluant was evaporated under oxygen-free nitrogen at 40 °C and the residue reduced and alkylated before overnight tryptic digestion. Protein digests were analysed using an Ultimate 3000 nano LC system coupled to a Q Exactive Plus Orbitrap mass spectrometer (ThermoScientific) as described previously 35 . The nano LC-MS/MS files obtained from the six different extracts were searched, combined and separately, using Peaks 8.5 software (BSI) against the human Swissprot database (downloaded on 26 October 2017). A tryptic digest setting was used and precursor and product ion tolerances were set at 10 p.p.m. and 0.05 Da respectively. The search parameters included a fixed modification of a carboxyamidomethylation on cysteine residues and variable modifications such as methionine oxidation, N-terminal pyro-glutamate, N-terminal acetylation and C-terminal amidation. A false discovery rate (FDR) value of 1% was applied at the peptide and a minimum of 1 unique peptide also was required. For further details, see Supplementary Methods. Statistics and reproducibility. All experiments reported in this study have been reproduced with similar results derived from independent samples (tissues and organoids) from several patients. The number of times the experiments were repeated with independently derived trophoblast organoid cultures are reported in the figure legends and summarized in Supplementary Table 1c . Given the descriptive nature of the work and biological variation between human samples, the experimental data points for each patient sample are shown separately unless stated otherwise. Trophoblast organoid culture protocols were independently replicated by four scientists. Statistical analyses used to analyse microarray, methylation and LC-MS/MS data are reported above. No statistical methods were used to predetermine sample size. The experiments were not randomized, and investigators were not blinded to allocation during experiments and outcome assessment unless stated otherwise (for example, see 'short tandem repeat analysis and HLA typing' section). Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. Code availability. Code used to analyse microarray data and EPIC array samples is available at https://github.com/CTR-BFX/2018-Turco-Moffett.
Data availability
Microarray data for Fig. 2 and Extended Data Figs. 4 and 5 have been deposited in the ArrayExpress database at EMBL-EBI under accession number E-MTAB-6683. Illumina EPIC methylation array data for Fig. 2 and Extended Data Fig. 5 have been deposited in the ArrayExpress database at EMBL-EBI under accession number E-MTAB-7204. The mass spectrometry proteomics data for Extended Data Table 3 and Supplementary Table 2 ELF3 and ELF5 both show moderate expression levels across the organoids and placental samples, and very low or no expression in the stromal samples. ELF4 and ELF1 are similar in all samples. There is very high expression of ELF1 in placentas and organoids. Similarly, both ERVW-1 and GCM1 are expressed at higher levels in placentas and organoids in agreement with qPCR data (Fig. 3d) . c, Genomic mapping of the methylation array probes to the ELF5 gene. The height of the bars indicates the methylation level from 0 (unmethylated) to 1.0 (fully methylated). d, Methylation of the ELF5 promoter shows hypomethylation in the organoid and placental samples. e, Distribution of methylcytosine across the promoters of the 10 trophoblast gatekeeper genes identified previously in mice 12 . The organoids (Org) and placental (Pl) samples show very similar methylation patterns across all 10 gene promoters that are distinct from the control brain (CL) and maternal blood (MB). Box plots comprise minimum: 1.5× interquartile range, bottom: first quartile, middle: median, top: third quartile, maximum: 1.5× interquartile range. *P < 0.01, Pearson's correlation coefficient. f, Table for a, PowerPlex16 short tandem repeat (STR) genotyping of DNA from matched maternal and fetal samples (maternal blood, decidua and placenta) to identify origin of organoids. The 15 STR loci analysed are shown. Numbered STR alleles observed for each DNA at a particular locus are listed within the relevant column. As expected, in most cases a maximum of two alleles was seen. In cases where there was evidence of an additional allele from a fetal-derived STR haplotype, the allele number appears in brackets. This is consistent with the decidua containing fetal extravillous trophoblast. The results at informative loci in which the fetal and trophoblast organoids match are underlined. b, HLA genotyping with third-generation single-molecule real-time sequencing of DNA from matched maternal blood and trophoblast organoid to confirm STR analysis. HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1 and HLA-DPB1 loci were investigated. The two HLA alleles at each locus defined at high resolution are shown for each sample. For each locus, the fetal trophoblast will share one allele with the mother but the other allele will be derived from the father and is likely to be different. Not all loci are informative as some paternal and non-inherited maternal alleles are the same. a, PowerPlex16 STR genotyping of DNA from matched maternal and fetal samples (decidua, maternal blood and placenta) to identify origin of organoids. The 15 STR loci analysed are shown. Numbered STR alleles observed for each DNA at a particular locus are listed within the relevant column. As expected, in most cases a maximum of two alleles was seen, but where there was lesser evidence of an additional allele from a fetal derived STR haplotype the allele number appears in brackets. The results at informative loci in which maternal blood, decidua and decidual organoids match are underlined. b, HLA genotyping with LABType reverse sequence-specific oligonucleotide probes (SSOP) of DNA from four pregnancies with matched decidua, blood, placenta and organoids. Each pair of HLA alleles defined, at low resolution, for each sample at a particular locus is listed within the relevant column. The maternal origin of the organoids is clear from HLA-A, HLA-B and HLA-C alleles in three of the four pregnancies. The data were inconclusive for pregnancy two, but all four organoids are clearly maternal in origin when using both methods (see above).
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